Impact of the COVID‐19 pandemic on people living with migraine: Results of the MiCOAS qualitative study

Buse, Dawn C.; Gerstein, Maya T; Houts, Carrie R.; McGinley, James S.; Uzumcu, A.; McCarrier, K.P.; Cooke, Alexis; Touba, Nancy M; Nishida, Tracy; Wirth, R.; Lipton, Richard B.

doi:10.1111/head.14274

Cited by 12 publications

(12 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given the timing of these interviews (July–November, 2020), participants were also provided an opportunity to discuss the impact of the COVID‐19 pandemic on various aspects of their experience with migraine (although having COVID‐19 was an exclusion criterion for participation). A sub‐analysis of this COVID‐19‐related inquiry is published separately 25 …”

Section: Methodsmentioning

confidence: 99%

Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study

Gerstein¹,

Wirth

Uzumcu³

et al. 2023

Headache

Self Cite

View full text Add to dashboard Cite

Objectives:To capture patients' perspectives on migraine-related cognitive symptoms during pre-headache, headache, post-headache, and interictal periods.Background: Migraine-related cognitive symptoms are reported by people with migraine both during and between attacks. Associated with disability, they are increasingly viewed as a priority target for treatment. The Migraine Clinical Outcome Assessment System (MiCOAS) project is focused on developing a patient-centered core set of outcome measures for the evaluation of migraine treatments. The project focuses on incorporating the experience of people living with migraine and the outcomes most meaningful to them. This includes an examination of the presence and functional impact of migrainerelated cognitive symptoms and their perceived impact on quality of life and disability.Methods: Forty individuals with self-reported medically diagnosed migraine were recruited via iterative purposeful sampling for semi-structured qualitative interviews conducted using audio-only web conferencing. Thematic content analysis was performed to identify key concepts around migraine-related cognitive symptoms.Recruitment continued until concept saturation was achieved.Results: Participants described symptoms consistent with migraine-related deficits in language/speech, sustained attention, executive function, and memory that manifest during pre-headache (36/40 [90%] reported ≥1 cognitive feature), headache (35/40 [88%] reported ≥1 cognitive feature), post-headache (27/40 [68%] reported ≥1 cognitive feature), and interictal periods (13/40 [33%] reported ≥1 cognitive feature). Among participants reporting cognitive symptoms during pre-headache, 32/40 (81%) endorsed 2-5 cognitive symptoms. Findings were similar during the headache phase. Participants reported language/speech problems consistent with, for example, impairments in receptive language, expressive language, and articulation. Issues with sustained attention included fogginess, confusion/disorientation, and trouble with concentration/focus. Deficits in executive function included difficulty processing How to cite this article: Gerstein MT, Wirth RJ, Uzumcu AA, et al. Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative study.

show abstract

Section: Methodsmentioning

confidence: 99%

Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study

Gerstein¹,

Wirth

Uzumcu³

et al. 2023

Headache

Self Cite

View full text Add to dashboard Cite

show abstract

“…In another study, data gathered for 3 months in Germany found no association between COVID‐19‐related restrictions and headache frequency or intensity 16 . Furthermore, a recent study in the United States reported both positive (i.e., increased access to care) and negative health outcomes (e.g., increased headache frequency, increased stress) during the pandemic compared to pre‐pandemic 17 . Findings regarding changes in migraine disability during the pandemic are thus inconsistent, perhaps in part because of utilization of differing samples and country‐specific mitigation strategies.…”

Section: Introductionmentioning

confidence: 93%

The effect of the COVID‐19 pandemic on headache‐related disability among young adults with migraine

Thaxter

Smitherman

2022

Headache

View full text Add to dashboard Cite

Objective The present study aimed to explore the relationship between the COVID‐19 pandemic and headache‐related disability among a sample of young adults with migraine. Background Comorbid psychological symptoms compound migraine‐related disability. Due to COVID‐19 pandemic procedures, many students experienced institutional closures and corresponding increases in depression, stress, and anxiety. The present study sought to examine changes in headache‐related disability before (Spring and Fall of 2019) and during (Fall of 2020 and Spring 2021) the COVID‐19 pandemic and whether psychological symptoms mediated such changes. Methods A cross‐sectional study at a southern U.S. university assessed 365 individuals with migraine on headache and psychological variables, comparing those surveyed before COVID‐19 with another group surveyed during the pandemic. The direct and indirect effects of COVID‐19 status (pre‐ versus during COVID‐19) on headache‐related disability through depression, anxiety, and stress symptoms were assessed. Results Statistically higher levels of depression, (M = 13.9 [SD = 12.2] vs. M = 8.7 [SD = 8.7], p < 0.001), anxiety (12.3 [10.0] vs. 9.7 [8.2], p = 0.01), and stress symptoms (17.6 [10.2] vs. 13.2 [7.9], p < 0.001) were endorsed during the COVID‐19 pandemic. The direct path from COVID‐19 status to headache‐related disability was significant and negative, c′ = −1.6 (95% CI: −3.1, −0.1). Anxiety (b = 0.3 [95% CI: 0.01, 0.9]) and depression (b = 0.7 [95% CI: 0.07, 1.4]) symptoms acted as mediators of this relationship, rendering the total effect nonsignificant and negating the lowered disability observed during the pandemic. Only depression symptoms remained a significant mediator after controlling for headache frequency (b = 0.7 [95% CI: 0.09, 1.4]). Conclusions Increased depression and anxiety symptoms attenuated the improvements in disability associated with the pandemic. As such, interventions that address comorbid psychological symptoms may hold value in reducing headache‐related disability and improving outcomes for young adults whose headache developed or worsened during the COVID‐19 pandemic.

show abstract

“…There is some evidence highlighting that headache is the most common neurological manifestation, which can occasionally be seen alone as the first sign of the disease (5)(6)(7)(8). Apart from the headaches associated with covid-19 infection, an increased number of headaches among the general population and those with a previous history of headaches could be referred to the lifestyle changes in the covid-19 era (9)(10)(11)(12). The other cause of headache at present is vaccination against covid- 19 (13-15).…”

Section: Introductionmentioning

confidence: 99%

A Review on Headaches Due to COVID-19 Infection

et al. 2022

View full text Add to dashboard Cite

Since December 2019, the time when the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was spotted, numerous review studies have been published on COVID-19 and its neuro invasion. A growing number of studies have reported headaches as a common neurological manifestation of COVID-19. Although several hypotheses have been proposed regarding the association between headache and the coronavirus, no solid evidence has been presented for the mechanism and features of headache in COVID-19. Headache also is a common complaint with the omicron variant of the virus. COVID-19 vaccination also is a cause of new-onset headaches or aggravation of the previous headache in migraine or tension headache sufferers. In this review study, the types of headaches reported in previous studies and their possible pathogenic mechanisms are outlined. To accomplish this objective, various types of headaches are classified and their patterns are discussed according to ICHD-3 diagnostic criteria, including, headaches attributed to systemic viral infection, viral meningitis or encephalitis, non-infectious inflammatory intracranial disease, hypoxia and/or hypercapnia, cranial or cervical vascular disorder, increased cerebrospinal fluid (CSF) pressure, refractive error, external-compression headache, and cough headache. Then, their pathogeneses are categorized into three main categories, direct trigeminal involvement, vascular invasion, and inflammatory mediators. Furthermore, persistent headache after recovery and the predictors of intensity is further investigated. Post-vaccination headache is also discussed in this review.

show abstract

Impact of the COVID‐19 pandemic on people living with migraine: Results of the MiCOAS qualitative study

Cited by 12 publications

References 29 publications

Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study

Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study

The effect of the COVID‐19 pandemic on headache‐related disability among young adults with migraine

A Review on Headaches Due to COVID-19 Infection

Contact Info

Product

Resources

About